Goldline Pharmaceutical IPO GMP History & Listing Result

Last GMP recorded

The last grey market premium recorded for Goldline Pharmaceutical SME IPO before listing, on 18 May 2026, 02:48 pm IST, was +₹15 (+34.9% over the issue price), implying a listing around ₹58 per share. Goldline Pharmaceutical listed at ₹59.75 (+38.95% versus the issue price) on May 19, 2026.

Current GMP
+15
(+34.9%)
▼ ₹2 vs yesterday
Updated May 18, 2026 02:48 pm
Issue Price
₹43
Band: ₹41 - ₹43
Expected Listing
₹58
Based on current GMP
Est. Gain / Lot
+₹90,000
+34.9% on listing
₹2,58,000 → ₹3,48,000 (6000 sh)

IPO Details

StatusListed
TypeSME
Open DateMay 12, 2026
Close DateMay 14, 2026
Listing DateMay 19, 2026
Issue Size₹12.00 Cr

GMP Trend

How Goldline Pharmaceutical’s GMP moved

DateGMP% of issue price
First quote08 May 2026₹6+14%
Highest13 May 2026₹25+58.1%
Lowest08 May 2026₹0+0%
Last before listing18 May 2026₹15+34.9%

Quoted on 9 days; the premium changed 11 times between readings.

The last GMP pointed to a listing near ₹58; the shares opened at ₹59.75 — a miss of 2.9%, and the direction was right. Across 117 SME IPOs we have measured, the average miss is 9.8%.

GMP History

Date GMP (Rs) Change GMP % Est. Listing
May 18, 2026 02:48 pm +15 ▼ 2 +34.9% ₹58
May 16, 2026 06:41 am +17 ▲ 2 +39.5% ₹60
May 14, 2026 05:20 pm +15 ▼ 10 +34.9% ₹58
May 13, 2026 05:07 pm +25 ▲ 11 +58.1% ₹68
May 13, 2026 04:39 pm +14 ▼ 4 +32.6% ₹57
May 12, 2026 08:03 pm +18 ▲ 1 +41.9% ₹61
May 11, 2026 07:28 pm +17 ▲ 1 +39.5% ₹60
May 11, 2026 02:02 pm +16 ▲ 1 +37.2% ₹59
May 10, 2026 08:49 am +15 ▲ 7 +34.9% ₹58
May 09, 2026 10:23 am +8 ▲ 2 +18.6% ₹51
May 08, 2026 04:30 pm +6 ▲ 6 +14.0% ₹49
May 08, 2026 12:30 pm +0 — +0.0% ₹43

Goldline Pharmaceutical IPO GMP — Detailed Analysis

What Goldline Pharmaceutical GMP Said Before Listing

The last Grey Market Premium recorded for Goldline Pharmaceutical IPO was Rs 15 (34.9% over the issue price). Based on this GMP, the implied listing price was around Rs 58 per share. Across the 12 GMP records captured for this issue, the trend was rising by Rs 15 before listing. Goldline Pharmaceutical listed at Rs 59.75 (+38.95% versus the issue price) on May 19, 2026.

Goldline Pharmaceutical IPO listed on May 19, 2026.

Goldline Pharmaceutical IPO GMP — FAQs

The last GMP recorded for Goldline Pharmaceutical IPO before listing was Rs 15 (34.9%). Goldline Pharmaceutical listed at Rs 59.75 (+38.95% versus the issue price) on May 19, 2026.

Goldline Pharmaceutical IPO listed on May 19, 2026.

The price band for Goldline Pharmaceutical IPO is Rs 41 to Rs 43 per share.

New to grey market data? The hub covers how to read a GMP trend and how SME GMP compares with actual listing performance, and our explainer goes deeper: What is IPO GMP?

GMP (Grey Market Premium) is based on unofficial market activity and does not guarantee listing price. IPO investments are subject to market risk. Please read the offer document before investing.
GMPUpdate